Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 3
2000 2
2001 1
2002 1
2003 1
2004 3
2005 2
2006 2
2007 1
2008 1
2009 2
2010 3
2011 5
2012 5
2013 6
2014 4
2015 4
2016 4
2017 3
2018 5
2019 1
2020 4
2021 4
2022 6
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab versus cyclophosphamide for ANCA-associated vasculitis.
Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh KA, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Specks U; RAVE-ITN Research Group. Stone JH, et al. N Engl J Med. 2010 Jul 15;363(3):221-32. doi: 10.1056/NEJMoa0909905. N Engl J Med. 2010. PMID: 20647199 Free PMC article. Clinical Trial.
Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis.
Atisha-Fregoso Y, Malkiel S, Harris KM, Byron M, Ding L, Kanaparthi S, Barry WT, Gao W, Ryker K, Tosta P, Askanase AD, Boackle SA, Chatham WW, Kamen DL, Karp DR, Kirou KA, Sam Lim S, Marder B, McMahon M, Parikh SV, Pendergraft WF 3rd, Podoll AS, Saxena A, Wofsy D, Diamond B, Smilek DE, Aranow C, Dall'Era M. Atisha-Fregoso Y, et al. Among authors: kirou ka. Arthritis Rheumatol. 2021 Jan;73(1):121-131. doi: 10.1002/art.41466. Epub 2020 Dec 1. Arthritis Rheumatol. 2021. PMID: 32755035 Free PMC article. Clinical Trial.
What Causes Lupus Flares?
Fernandez D, Kirou KA. Fernandez D, et al. Among authors: kirou ka. Curr Rheumatol Rep. 2016 Mar;18(3):14. doi: 10.1007/s11926-016-0562-3. Curr Rheumatol Rep. 2016. PMID: 26951252 Review.
Type I Interferons in Autoimmune Disease.
Crow MK, Olferiev M, Kirou KA. Crow MK, et al. Among authors: kirou ka. Annu Rev Pathol. 2019 Jan 24;14:369-393. doi: 10.1146/annurev-pathol-020117-043952. Epub 2018 Oct 17. Annu Rev Pathol. 2019. PMID: 30332560 Review.
Anti-interferon alpha treatment in SLE.
Kirou KA, Gkrouzman E. Kirou KA, et al. Clin Immunol. 2013 Sep;148(3):303-12. doi: 10.1016/j.clim.2013.02.013. Epub 2013 Mar 1. Clin Immunol. 2013. PMID: 23566912 Review.
Identification of Candidate Predictors of Lupus Flare.
Crow MK, Olferiev M, Kirou KA. Crow MK, et al. Among authors: kirou ka. Trans Am Clin Climatol Assoc. 2015;126:184-96. Trans Am Clin Climatol Assoc. 2015. PMID: 26330673 Free PMC article. Review.
Type I interferons as biomarkers in autoimmune diseases.
Kalliolias GD, Kirou KA. Kalliolias GD, et al. Among authors: kirou ka. Biomark Med. 2012 Apr;6(2):137-40. doi: 10.2217/bmm.12.8. Biomark Med. 2012. PMID: 22448787 Free article. No abstract available.
65 results